SCHEMBL2282335

SCHEMBL2282335

O=[N+]([O-])C(CCC(O)S(=O)(=O)[O-])CCC(O)S(=O)(=O)[O-].[Na+].[Na+]

nearest known ligand 0.00

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695398 0.82 MEN1 (0.39)
SCHEMBL12083643 0.81
SCHEMBL14847493 0.81
SCHEMBL2282338 0.79
SCHEMBL12083804 0.73
SCHEMBL8441359 0.72 MEN1 (0.35)
SCHEMBL29994889 0.71 CA1 (0.39)
SCHEMBL28513985 0.70 TP53 (0.38)
SCHEMBL15420991 0.69 MEN1 (0.32)
SCHEMBL5300717 0.69 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2196454-B1 EXO-AND DIASTEREO-SELECTIVE SYNTHESES OF HIMBACINE ANALOGS MERCK SHARP & DOHME (US) 2014-08-27 EP disclosed
US-8618314-B2 Exo- and diastereo-selective synthesis of himbacine analogs MERCK SHARP & DOHME CORP. (US) 2013-12-31 US disclosed
EP-2196468-B1 Exo-and diastereo-selective syntheses of himbacine analogs MERCK SHARP & DOHME (US) 2013-04-10 EP disclosed
US-20120296093-A1 EXO- AND DIASTEREO- SELECTIVE SYNTHESIS OF HIMBACINE ANALOGS TOPROL ACQUISITION LLC 2012-11-22 US disclosed
US-8258319-B2 Exo- and diastereo- selective synthesis of himbacine analogs SCHERING CORPORATION (US) 2012-09-04 US disclosed
EP-2206697-B1 Exo- and diastereo-selective syntheses of himbacine analogs SCHERING CORP (US) 2011-10-26 EP disclosed
US-20110251392-A1 EXO- AND DIASTEREO- SELECTIVE SYNTHESIS OF HIMBACINE ANALOGS TOPROL ACQUISITION LLC 2011-10-13 US disclosed
US-7989653-B2 Exo- and diastereo-selective syntheses of himbacine analogs SCHERING CORPORATION (US) 2011-08-02 US disclosed
EP-2206697-A1 Exo- and diastereo-selective syntheses of himbacine analogs SCHERING CORPORATION (US) 2010-07-14 EP disclosed
EP-2196468-A1 Exo-and diastereo-selective syntheses of himbacine analogs SCHERING CORPORATION (US) 2010-06-16 EP disclosed
EP-2196454-A2 Exo-and diastereo-selective syntheses of himbacine analogs SCHERING CORPORATION (US) 2010-06-16 EP disclosed
EP-1848705-B1 EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS SCHERING CORP (US) 2010-02-24 EP disclosed
US-20090281321-A1 EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS SCHERING CORPORATION 2009-11-12 US disclosed
US-7605275-B2 Cyclization of 1-(1-(diphenylaminocarbonyl-vinyl-)ethyl-oxycarbonyl-vinyl-),5-nitro-)cyclohex-1-ene by heating in a solvent to form an trans-(5,6)ring junction and an endoisomer(cis) isomer of 3-(oxo),6-(nitro),9-diphenylamido-perhydro-4,4a-didehydronaphtho(2,3)furan SCHERING CORPORATION (US) 2009-10-20 US disclosed
EP-1848705-A2 EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS SCHERING CORPORATION (US) 2007-10-31 EP disclosed
US-20060247450-A1 Exo- and diastereo- selective syntheses of himbacine analogs SCHERING CORPORATION 2006-11-02 US disclosed
WO-2006076415-A2 EXO- AND DIASTEREO- SELECTIVE SYNTHESES OF HIMBACINE ANALOGS SCHERING CORPORATION (US) 2006-07-20 WO disclosed